THANK YOU FOR SUBSCRIBING
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Share this Article:
Tweet
|
Company
Neuronetics
Headquarters
Malvern, PA
Management
Chris Thatcher, President & CEO
Description
Pennsylvania-based Neuronetics develops non-invasive, non-systemic therapeutic solutions that offer psychiatrists an alternative way to renew and restore the lives of patients with psychiatric disorders. The company’s solution, NeuroStar Advanced Therapy, is backed by extensive research performed intop clinical trial facilities. Information on NeuroStar’s efficacy, durability, and safety profile has been a part of 11 clinical studies with 24 peer-reviewed publications. Furthermore, the company provides clinical training and other post-implementation support services, which facilitate psychiatrists to leverage NeuroStar to its fullest capabilities
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
However, if you would like to share the information in this article, you may use the link below:
neurology.medicaltechoutlook.com/vendor/neuronetics-transforming-neurohealth-cid-662-mid-66.html